Week of March 21st 2022 | Vol. 11, Issue 12
|
|
|
In This Issue
Upcoming Events
Industry M&A Activity
Recent Transactions
Trading Comps
Market Reports
M&A Pipeline
Featured Headlines
Tanner Updates
Quick Links
Contact Information
Managing Director
Business Development
Managing Director
Head of M&A and Capital Advisory
|
|
Above is an overview of recent industry M&A activity. Click on the chart to download complete transaction tables broken out by industry sub sectors. For additional information, see the Industry M&A Activity section below.
|
|
Events Hosted or Attended by Bourne Partners
|
|
|
March 21-24, 2022 - New York City, NY
|
|
|
May 17-19, 2022 - Philadelphia, PA
|
|
|
May 24-26, 2022 - New York City, NY
|
|
|
April 23-26, 2022 - Palm Beach, FL
|
|
|
June 13-16, 2022 - San Diego, CA
|
|
|
August 27-29, 2022 - Boston, MA
|
|
|
October 2022 - Charlotte, NC
|
|
INDUSTRY M&A ACTIVITY
Recent Transactions, Trading Comps, Market Reports, M&A Pipeline
|
|
RECENT TRANSACTIONS
An Overview of Transactions Within Market Sub-segments
|
|
Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.
|
|
|
Pharma & Biotech
9 transactions
Supplies, Equipment & Services
25 transactions totaling $725 million
Healthcare IT & Managed Care
9 transactions totaling $21 million
Healthcare Facilities & Distributors
9 transactions totaling $12 million
|
|
|
Pharma & Biotech
33 transactions totaling $1,061 million
Supplies, Equipment & Services
29 transactions totaling $372 million
Healthcare IT & Managed Care
20 transactions totaling $627 million
Healthcare Facilities & Distributors
0 transactions
|
|
|
Pharma & Biotech
14 transactions totaling $1,014 million
Supplies, Equipment & Services
4 transactions totaling $53 million
Healthcare IT & Managed Care
2 transactions totaling $47 million
Healthcare Facilities & Distributors
1 transaction
|
|
TRADING COMPS
A Breakdown of Relevant Trading Multiples
|
|
|
This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.
For a complete trading comp analysis (including the individual equities that comprise the sub sectors), click on the table.
Note: data reflects prior week close.
|
|
MARKET REPORTS
Insight Into Healthcare Related Industries
|
|
M&A PIPELINE
Representative Current Retained Sell-Side And Partnering Opportunities
|
|
Project Focus
Sell-side | CMO | Liquids and Semi-solids CMO headquartered in North America
Project Nucleus
Buy-side| CDMO | North American radiopharmaceutical company
|
|
Project Power Play
Buy-side | Specialty Pharma | In-license and acquire approved Rx products including legacy brands, generics, and niche launch-ready products
Project Trident
Buy-side | Generic Pharma | Manufacturing liquid generics
|
|
FEATURED HEADLINES
A Sampling of Industry Headlines From Last Week
|
|
During a multihour hike in the hills of Arizona interspersed with cactus lessons, female CEOs fostered a "biotech sisterhood" aimed at lifting up their peers in the industry.
Two dozen female biotech CEOs—about half of the total invite list—came together in Tucson this past weekend for what they described as a first-of-its-kind retreat to network, create the basis for longer-term visions and bounce ideas off one another in the pursuit of supporting women in the industry.
Their mission coalesced around an unmet need, a term oft-cited in drug development. About 23% of biotech CEOs identify as women, according to a Biotechnology Innovation Organization (BIO) report from 2021.
|
|
March 16, 2022 - Fierce Biotech
|
With a new $987 million fund, Frazier Life Sciences is ready to form another four or five new biotechs over the next 12 months and bankroll early-stage investing in other nascent drug development startups.
|
|
March 16, 2022 - Fierce Pharma
|
Since the invasion of Ukraine, hundreds of companies have announced a pause or withdrawal of businesses in Russia.
|
|
March 16, 2022- Fierce Pharma
|
Homegrown mRNA players BioNTech and CureVac have signed on to supply Germany with vaccines against future health emergencies for years to come.
|
|
March 17, 2022- Fierce Biotech
|
With artificial intelligence being treated as the next frontier of drug discovery and cell research, efforts to fine-tune the technology are expanding, which is music to the ears of investors that see dollar signs when they hear “machine learning.”
|
|
The work of TannerGAP includes addressing medicine market withdrawal, post-clinical trial solutions, mitigating drug shortages and managing medicine supply on a Named Patient basis. Learn more from TannerGAP EVP, Maryori Alvarenga.
|
|
When demand for PPE and testing kits surged to unparalleled levels in March 2020 during the first wave of Covid-19, Tanner had to do something to help. Learn more about the development of TannerGMS (global medical supplies) and the future of medical supplies and diagnostics here.
|
|
The Tanner team will be attending several networking events in the coming weeks. Let’s connect to discuss how our organizations can improve patient lives, together.
|
|
|
|
|
|
|